{"id":2029,"date":"2019-11-11T12:39:53","date_gmt":"2019-11-11T12:39:53","guid":{"rendered":"https:\/\/xspraypharma.com\/investerare\/bolagsstyrning\/styrelse-utskott-copy\/"},"modified":"2026-05-13T13:40:05","modified_gmt":"2026-05-13T13:40:05","slug":"styrelse-utskott","status":"publish","type":"page","link":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/","title":{"rendered":"Styrelse och utskott"},"content":{"rendered":"\n
\n\t
\n\t\t\t\t\t
\n\t\t\t\t

Styrelse och utskott<\/h1>\n\t\t\t<\/header>\n\t\t\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t

Styrelse:<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Anders Ekblom<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseordf\u00f6rande\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot tillika Styrelseordf\u00f6rande sedan 2021
\r\nOrdf\u00f6rande i Ers\u00e4ttningsutskottet
\r\nF\u00f6dd 1954\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tL\u00e4kare, specialist i anestesi och intensivv\u00e5rd, tandl\u00e4kare och docent i fysiologi vid Karolinska Institutet\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\tStyrelseordf\u00f6rande i Atrogi AB, styrelseledamot i Synkerkine Pharma B.V., Flerie AB, Mereo BioPharma Group plc och NxtScience AB, samt styrelsesuppleant i Xspray Pharma Futurum AB
\r\n
\r\nInnehav i Bolaget: 6 050 aktier, 13 214 teckningsoptioner (LTIP 2021\/2026)
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till bolaget men beroende till st\u00f6rre aktie\u00e4gare.\t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Anders Bladh<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2021
\r\nOrdf\u00f6rande i Revisionsutskottet
\r\nF\u00f6dd 1958
\r\n\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tInternationell ekonomexamen, Uppsala universitet\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\t\u00c4gare och styrelseordf\u00f6rande i Intervalor AB och Rimturs AB, \u00e4gare i Ribbskottet AB samt styrelseledamot i Umecrine Cognition AB
\r\n
\r\nInnehav i Bolaget: 4 757 642 aktier via Ribbskottet AB och 304 200 aktier privat
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till bolaget men beroende till st\u00f6rre aktie\u00e4gare.\t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Markus Haeberlein<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2025
\r\nBosatt i USA
\r\nLedamot i Ers\u00e4ttningsutskottet
\r\nF\u00f6dd 1969\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tM.Sc. and Ph.D. in Physical Chemistry\/Computational Chemistry fr\u00e5n Kungliga Tekniska H\u00f6gskolan, KTH, Stockholm\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\tExecutive Vice President , Discovery Science at Parabilis Medicines, Cambridge, Massachusetts, USA
\r\n
\r\nInnehav i bolaget: 0
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till s\u00e5v\u00e4l bolaget och dess ledning som till st\u00f6rre aktie\u00e4gare \t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Christine Lind<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2019
\r\nF\u00f6dd 1974\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tBachelors in Science in Finance and Information Systems, New York University, samt Masterexamen i Business Administration in Finance and Management, Columbia Business School.\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\tVerkst\u00e4llande direkt\u00f6r i Bactiguard AB och Bactiguard Holding AB, verkst\u00e4llande direkt\u00f6r tillika styrelseordf\u00f6rande i Lind Growth Strategy AB, samt styrelsesuppleant i Shinka Life Sciences AB
\r\n
\r\nInnehav i Bolaget: 8 104 aktier
\r\n
\r\nOberoende till s\u00e5v\u00e4l bolaget och dess ledning som till st\u00f6rre aktie\u00e4gare\t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Robert Molander<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2022
\r\nLedamot i Ers\u00e4ttningsutskottet
\r\nBosatt i USA
\r\nF\u00f6dd 1965
\r\n\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tMBA fr\u00e5n Washington University samt tv\u00e5 kandidatexamina fr\u00e5n Miami University i Economics och International Studies\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\t\u00c4gare och VD i Stratfox Healthcare Group LLC, del\u00e4gare i IRL MD Food Solutions, samt styrelseledamot i SciBase Intressenter AB, SciBase Holding AB (publ), SciBase AB och Biosergen AB
\r\n
\r\nInnehav i Bolaget: 10 000 aktier
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till s\u00e5v\u00e4l bolaget och dess ledning som till st\u00f6rre aktie\u00e4gare\t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Anne Prener<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2025
\r\nLedamot i Revisionsutskottet
\r\nBosatt i Danmark
\r\nF\u00f6dd 1957\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tL\u00e4kare, Ph.D. fr\u00e5n K\u00f6penhamns Universitet
\r\n
\r\n\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\tSenior Innovation Advisor vid K\u00f6penhamns Universitet, extern styrelseledamot i Galecto Inc.
\r\n
\r\nInnehav i bolaget: 0
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till s\u00e5v\u00e4l bolaget och dess ledning som till st\u00f6rre aktie\u00e4gare \t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t
\n\t\t\t\t\t\"\"\t\t\t<\/figure>\n\n\t
\n\n\t\t

Carl-Johan Spak<\/h3>\n\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tStyrelseledamot sedan 2015
\r\nLedamot i Revisionsutskottet
\r\nF\u00f6dd 1956\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUtbildning:<\/strong>\n\t\t\t\tOdontologie doktor, Tandl\u00e4karexamen, Karolinska Institutet\t\t\t<\/p>\n\t\t\n\t\t\t\t\t

\n\t\t\t\tUppdrag:<\/strong>\n\t\t\t\tStyrelseledamot i EpiEndo ehf, Lipum AB (publ) samt Buzzard Pharmaceuticals AB
\r\n
\r\nInnehav i Bolaget: 0
\r\n
\r\nOberoende i f\u00f6rh\u00e5llande till s\u00e5v\u00e4l bolaget och dess ledning som till st\u00f6rre aktie\u00e4gare\t\t\t<\/p>\n\t\t\n\t\t\t\t\n\t<\/div>\n<\/article>\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t<\/section>\n\n\t\t\t\t\t\t\n\t\t\t\t\n\t<\/div>\n<\/section>\n\n\n

\n\t\t\t\t\t\t
\n\t\t\t\t

Utskott<\/h1>\n

Revisionsutskott<\/p>\n

    \n
  • Christine Lind, ordf\u00f6rande<\/li>\n
  • Anne Prener<\/li>\n
  • Carl-Johan Spak<\/li>\n<\/ul>\n

    Ers\u00e4ttningsutskott<\/p>\n

      \n
    • Anders Ekblom, ordf\u00f6rande<\/li>\n
    • Markus Haeberlein<\/li>\n
    • Robert Molander<\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t\t<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1707,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2029","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nStyrelse och utskott - Xspray<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Styrelse och utskott - Xspray\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/\" \/>\n<meta property=\"og:site_name\" content=\"Xspray\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-13T13:40:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/\",\"url\":\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/\",\"name\":\"Styrelse och utskott - Xspray\",\"isPartOf\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\"},\"datePublished\":\"2019-11-11T12:39:53+00:00\",\"dateModified\":\"2026-05-13T13:40:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/xspraypharma.com\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Om oss\",\"item\":\"https:\/\/xspraypharma.com\/sv\/om-oss\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Styrelse och utskott\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\",\"url\":\"https:\/\/xspraypharma.com\/sv\/\",\"name\":\"Xspray\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Styrelse och utskott - Xspray","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/","og_locale":"sv_SE","og_type":"article","og_title":"Styrelse och utskott - Xspray","og_url":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/","og_site_name":"Xspray","article_modified_time":"2026-05-13T13:40:05+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/","url":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/","name":"Styrelse och utskott - Xspray","isPartOf":{"@id":"https:\/\/xspraypharma.com\/sv\/#website"},"datePublished":"2019-11-11T12:39:53+00:00","dateModified":"2026-05-13T13:40:05+00:00","breadcrumb":{"@id":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/xspraypharma.com\/sv\/om-oss\/styrelse-utskott\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xspraypharma.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Om oss","item":"https:\/\/xspraypharma.com\/sv\/om-oss\/"},{"@type":"ListItem","position":3,"name":"Styrelse och utskott"}]},{"@type":"WebSite","@id":"https:\/\/xspraypharma.com\/sv\/#website","url":"https:\/\/xspraypharma.com\/sv\/","name":"Xspray","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/2029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/comments?post=2029"}],"version-history":[{"count":20,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/2029\/revisions"}],"predecessor-version":[{"id":11407,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/2029\/revisions\/11407"}],"up":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/1707"}],"wp:attachment":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/media?parent=2029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}